HF004
In those patients with a current diagnosis of heart failure due to left ventricular systolic dysfunction who are currently treated with an ACE-I or ARB, the percentage of patients who are additionally currently treated with a beta- blocker licensed for heart failure for heart failure
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF004 | 2015 | 373 | 406 | 91.9% | |
| HF004 | 2016 | 447 | 479 | 93.3% | |
| HF004 | 2017 | 577 | 637 | 90.6% | |
| HF004 | 2018 | 674 | 729 | 92.5% | |
| HF004 | 2019 | 715 | 768 | 93.1% | |
| HF004 | 2020 | 814 | 879 | 92.6% | |
| HF004 | 2021 | 920 | 1008 | 91.3% |
